Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003076295 | SCV003448477 | likely benign | not provided | 2024-09-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070275 | SCV003694126 | uncertain significance | not specified | 2021-10-12 | criteria provided, single submitter | clinical testing | The c.154G>A (p.D52N) alteration is located in exon 4 (coding exon 3) of the BLVRA gene. This alteration results from a G to A substitution at nucleotide position 154, causing the aspartic acid (D) at amino acid position 52 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |